Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study on the Effect of 40 Hz Non-Invasive Light Therapy System
Sponsor: Zealand University Hospital
Summary
The ALZLIGHT STAGE III Study is a continuation of the ALZLIGHT Pilot - Study on Safety, Feasibility and Neural Activation of Non-Invasive Light Therapy System. As with the first two stages, this study will examine whether entrainment of 40 Hz neural oscillation by novel 40 Hz Invisible Spectral Flicker is a potential therapy for Alzheimer's Disease. In order to examine this, 62 patients with mild to moderate Alzheimer's Disease will be recruited. The patients will be exposed to the Non-Invasive Light Therapy System for 1 hour a day for 6 months. The effect will be measured by a combination of electroencephalography, cognitive testing, functional magnetic resonance imaging, magnetic resonance spectroscopy and actigraphy.
Official title: ALZLIGHT Stage III - Study on the Effect of 40 Hz Non-Invasive Light Therapy System
Key Details
Gender
All
Age Range
55 Years - Any
Study Type
INTERVENTIONAL
Enrollment
62
Start Date
2022-09-20
Completion Date
2026-12-01
Last Updated
2024-01-24
Healthy Volunteers
No
Conditions
Interventions
Light Therapy System (LTS): Active Setting
Exposure for 1 hour á day for consecutive days
Light Therapy System (LTS): Sham Setting
Exposure for 1 hour á day for consecutive days
Locations (1)
Zealand University Hospital
Roskilde, Denmark